Beat-Sc: Phase Iii Trial Of Bevacizumab Or Placebo With Atezolizumab & Chemo In Extensive-Stage Sclc

BEAT-SC: Phase III trial of bevacizumab or placebo with atezolizumab & chemo in extensive-stage SCLC

BEAT-meso: Phase III trial of bevacizumab and chemo ± atezolizumab for advanced pleural mesothelioma

Key outcomes of the Phase 1b of atezolizumab and bevacizumab for advanced HCC

Combination Atezolizumab Plus Bevacizumab Improved Quality of Life in HCC

Targeted Oncology

Dr. Krishnansu Tewari on a Phase III Trial Exploring Bevacizumab in Recurrent Cervical Cancer

Targeted Oncology

AURELIA: Phase 3 trial of bevacizumab combined with chemotherapy for ovarian cancer

EMJ

IMpower150 update from ELCC: atezolizumab and bevacizumab improve survival

CALGB 90601: Comparing gemcitabine and cisplatin with bevacizumab to placebo for metastatic urot...

Gibbs: SIRFLOX Phase III Colorectal Cancer Trial Results

Cancer Therapy Advisor

GS1-08: "CCTGMA.32, a phase III randomized double-blind placebo controlled adjuvant trial of..."

San Antonio Breast Cancer Symposium

Clinical Trial: Atezolizumab for Melanoma (NCT05116202)

Power Life Sciences

FIRE-3 Study: Cetuximab Versus Bevacizumab in Metastatic Colorectal Cancer

Immunotherapy in Stage III NSCLC: Practice-Changing Results of PACIFIC Trial (BMIC-006)

Atezolizumab in metastatic TNBC: Long-term clinical outcomes and biomarker analyses

Phase 3 RECOURSE trial of TAS-102 vs placebo

IMPower150: Implications for the Treatment of NSCLC

Are there placebos in myeloma clinical trials?

HealthTree University for Multiple Myeloma

Updates on the SECOMBIT trial

Broken Science Newsletter June 5, 2024 #bsi

The Broken Science Initiative

RECOURSE Trial: Phase III trial: The Onset of Neutropenia as a Treatment Response Indicator